Login / Signup

The use of tranexamic acid to reduce blood loss in uncemented total hip arthroplasty for avascular necrosis of femoral head: a prospective blinded randomized controlled study.

Javahir A PachoreVikram Indrajit ShahSachin UpadhyayKalpesh ShahAshish ShethAmish Kshatriya
Published in: Arthroplasty (London, England) (2019)
A single dose of TXA used preoperatively may minimize intraoperative, postoperative, and total blood loss in uncemented THA for the treatment of osteonecrosis of femoral head, and may not increase the risk of prothrombotic complications.
Keyphrases
  • total hip arthroplasty
  • placebo controlled
  • patients undergoing
  • double blind
  • total hip
  • open label
  • risk factors
  • phase iii
  • study protocol
  • randomized controlled trial
  • combination therapy